Literature DB >> 17761609

The use of osteoconductive bone graft substitutes in orthopaedic trauma.

David J Hak1.   

Abstract

Several bone graft substitutes are now available for use in augmenting bone healing following trauma. Many of these products are osteoconductive and are indicated for filling bone defects in conjunction with standard methods of internal and external fixation. Osteoconduction refers to a process in which the three-dimensional structure of a substance is conducive for the ongrowth and/or ingrowth of newly formed bone. Currently used bone graft substitutes that primarily offer osteoconductive properties include coralline hydroxyapatite, collagen-based matrices, calcium phosphate, calcium sulfate, and tricalcium phosphate. These products vary considerably in chemical composition, structural strength, and resorption or remodeling rates. Understanding these differences is important in selecting a bone graft substitute with the properties desired for a specific clinical situation. The limited number of clinical studies and lack of direct-comparison studies between these products require the surgeon to fully understand the properties of each product when choosing a bone graft substitute.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761609     DOI: 10.5435/00124635-200709000-00003

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  56 in total

Review 1.  [Bone substitutes].

Authors:  M Schieker; C Heiss; W Mutschler
Journal:  Unfallchirurg       Date:  2008-08       Impact factor: 1.000

2.  [Non-unions. From diagnosis to healing].

Authors:  E Steinhausen; M Glombitza; H-J Böhm; P-M Hax; D Rixen
Journal:  Unfallchirurg       Date:  2013-07       Impact factor: 1.000

Review 3.  The role of mesenchymal stem cells in bone repair and regeneration.

Authors:  Pavel Sponer; Tomáš Kučera; Daniel Diaz-Garcia; Stanislav Filip
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-10-08

Review 4.  Scaffold translation: barriers between concept and clinic.

Authors:  Scott J Hollister; William L Murphy
Journal:  Tissue Eng Part B Rev       Date:  2011-09-21       Impact factor: 6.389

5.  Porous bioactive scaffolds: characterization and biological performance in a model of tibial bone defect in rats.

Authors:  Hueliton Wilian Kido; Carla Roberta Tim; Paulo Sérgio Bossini; Nivaldo Antônio Parizotto; Cynthia Aparecida de Castro; Murilo Camuri Crovace; Ana Candida Martins Rodrigues; Edgar Dutra Zanotto; Oscar Peitl Filho; Fernanda de Freitas Anibal; Ana Claudia Muniz Rennó
Journal:  J Mater Sci Mater Med       Date:  2015-01-29       Impact factor: 3.896

6.  Temperature-responsive PNDJ hydrogels provide high and sustained antimicrobial concentrations in surgical sites.

Authors:  Derek J Overstreet; Vajra S Badha; John M Heffernan; Erin P Childers; Rex C Moore; Brent L Vernon; Alex C McLaren
Journal:  Drug Deliv Transl Res       Date:  2019-08       Impact factor: 4.617

7.  Effects of particle size and porosity on in vivo remodeling of settable allograft bone/polymer composites.

Authors:  Edna M Prieto; Anne D Talley; Nicholas R Gould; Katarzyna J Zienkiewicz; Susan J Drapeau; Kerem N Kalpakci; Scott A Guelcher
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2015-01-08       Impact factor: 3.368

8.  Microvascular response to calcium phosphate bone substitutes: an intravital microscopy analysis.

Authors:  Bernd Roetman; Andrej Ring; Stefan Langer; Thomas A Schildhauer; Gert Muhr; Manfred Köller
Journal:  Langenbecks Arch Surg       Date:  2010-03-07       Impact factor: 3.445

9.  Mineral coatings for temporally controlled delivery of multiple proteins.

Authors:  Jae Sung Lee; Darilis Suarez-Gonzalez; William L Murphy
Journal:  Adv Mater       Date:  2011-10-04       Impact factor: 30.849

Review 10.  Bone grafts, bone substitutes and orthobiologics: the bridge between basic science and clinical advancements in fracture healing.

Authors:  Timothy T Roberts; Andrew J Rosenbaum
Journal:  Organogenesis       Date:  2012-10-01       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.